MedPath

Carbohydrate Restriction for Gestational Diabetes Mellitus

Not Applicable
Completed
Conditions
Gestational Diabetes Mellitus (GDM)
Interventions
Dietary Supplement: High CHO diet
Behavioral: Low CHO
Registration Number
NCT00911404
Lead Sponsor
Hospital Arnau de Vilanova
Brief Summary

There is evidence that controlling total amount of carbohydrates is a strategy for controlling glucose levels in diabetes mellitus. There is not major evidence that any given macronutrient percentage may be recommended to treat a woman with Gestational Diabetes Mellitus (GDM). In the investigators' country, insulin is the second-line treatment once medical nutrition therapy (MNT) has failed to control glucose levels during pregnancy. Insulin treatment is more expensive and not as well accepted as MNT. The investigators have designed a randomized-controlled trial to assess whether a diet with 40% total calories from carbohydrates may reduce the need of insulin treatment in women with gestational diabetes, without having unfavourable pregnancy outcomes, in comparison with a diet with 55% total calories from carbohydrates.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
152
Inclusion Criteria
  • Gestational diabetes mellitus
  • Single pregnancy
Exclusion Criteria
  • Multiple pregnancy
  • High risk pregnancy (any other concomitant illness, excluding hypertension and obesity)
  • Low ability to understand and follow a diet
  • Need to use insulin different from regular insulin

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High CHOHigh CHO dietDiet with 55% total calories from carbohydrates.
Low CHOLow CHODiet with 40% total calories from carbohydrates.
Primary Outcome Measures
NameTimeMethod
Need of insulin treatment for GDMDay of delivery
Secondary Outcome Measures
NameTimeMethod
Maternal morbidityDay of delivery
Maternal ketonemia and/or ketonuriaDay of delivery
Time from GDM diagnosis free of insulin treatmentDay of delivery
Fetal morbidity1 month after delivery

Trial Locations

Locations (1)

Hospital Universitari Arnau de Vilanova

🇪🇸

Lleida, Spain

© Copyright 2025. All Rights Reserved by MedPath